7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
Key Takeaways
- MASD encompasses four distinct clinical categories: Incontinence-Associated Dermatitis (IAD), Intertriginous Dermatitis (ITD/Intertrigo), Periwound MASD, and Peristomal MASD.
- Incontinence-Associated Dermatitis (IAD) is a top-down chemical injury caused by alkaline urine pH activating fecal lipases and proteases, breaking down stratum corneum lipid bilayers.
- IAD presents as diffuse, irregular, blotchy erythema in skin folds/perineum without necrotic tissue, slough, or eschar; Stage 1/2 pressure injuries occur over bony prominences with circumscribed borders.
- Skin barrier protectants include petrolatum (occlusive base), dimethicone (breathable silicone barrier), zinc oxide (thick physical barrier for enzymatic stool), and cyanoacrylates (polymeric film for denuded skin).
- Secondary Candida albicans superinfection in IAD/ITD presents with fiery red erythema and characteristic satellite macules/pustules, requiring topical antifungal powder/cream.
7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
Moisture-Associated Skin Damage (MASD) encompasses a spectrum of cutaneous inflammatory conditions caused by prolonged exposure of the skin to various moisture sources, including urine, feces, perspiration, wound exudate, and digestive secretions. A core competency evaluated on the Certified Wound Specialist (CWS) examination is the precise clinical differentiation between MASD—specifically Incontinence-Associated Dermatitis (IAD)—and pressure injuries. Misdiagnosing IAD as a pressure injury leads to inappropriate treatment strategies, misallocation of clinical resources, and inaccurate quality reporting.
Pathophysiology & Etiology of MASD
Healthy skin functions as a protective barrier maintained by the stratum corneum, an acidic skin mantle (pH 4.5 – 5.5), and tightly organized intercellular lipid bilayers. Exposure to excessive moisture breaks down this protective barrier through several mechanisms:
- Stratum Corneum Overhydration (Maceration): Hyperhydration disrupts intracellular keratin filament bundles and expands intercellular lipid spaces, causing swelling, softening, and loss of skin structural integrity. Macerated skin exhibits a characteristic pale, waterlogged, wrinkled appearance.
- Loss of Barrier Function: Maceration dramatically increases skin permeability to chemical irritants and pathogens, while increasing susceptibility to friction-induced epidermal stripping (denudation).
- Alkaline pH Shift & Enzymatic Activation: In the setting of incontinence, urea-splitting bacteria convert urinary urea into ammonia, elevating skin pH into an alkaline range (> 7.0). Alkaline pH activates digestive enzymes present in feces—specifically lipases and proteases. Active proteases degrade stratum corneum proteins (corneodesmosomes), while lipases break down intercellular lipids, resulting in rapid chemical digestion of the epidermis.
The Four Clinical Categories of MASD
MASD is classified into four distinct clinical entities based on moisture source and anatomical location:
1. Incontinence-Associated Dermatitis (IAD)
- Definition: Inflammation and superficial erosion of the skin secondary to liquid contact with urine or stool.
- Anatomical Distribution: Perineum, perianal region, gluteal cleft, upper inner thighs, and lower abdomen.
- Risk Factors: Liquid stool (diarrhea), dual incontinence (fecal + urinary), frequent bowel movements, impaired mobility, and cognitive impairment. Fecal incontinence presents a significantly higher risk than urinary incontinence alone due to active digestive enzymes.
2. Intertriginous Dermatitis (ITD / Intertrigo)
- Definition: Inflammatory skin condition caused by friction between opposing skin folds combined with trapped perspiration and inadequate air circulation.
- Anatomical Sites: Inframammary folds, abdominal pannicus folds, axillae, groin folds, and gluteal cleft.
- Features: Linear mirror-image erythema along the base of the skin fold, often accompanied by maceration, erosion, and a characteristic musty odor. Secondary fungal overgrowth (Candida albicans) is extremely common.
3. Periwound MASD
- Definition: Maceration and breakdown of skin immediately surrounding a chronic wound (within 4 cm of wound margin).
- Etiology: Sustained contact with highly exudative wounds. Chronic wound exudate contains elevated levels of inflammatory cytokines, matrix metalloproteinases (MMPs), and bacteria, which degrade native periwound skin proteins.
4. Peristomal MASD
- Definition: Inflammation and erosion of skin surrounding a stoma (e.g., ileostomy, colostomy, urostomy).
- Etiology: Corrosive stomal effluent (particularly liquid fecal effluent rich in pancreatic enzymes from an ileostomy) leaking beneath an ill-fitting pouching system barrier wafer.
Differential Diagnosis: IAD vs. Stage 1 / Stage 2 Pressure Injury
Accurate clinical distinction between IAD and pressure injuries is a frequent, high-yield CWS exam topic.
| Diagnostic Parameter | Incontinence-Associated Dermatitis (IAD) | Pressure Injury (Stage 1 or Stage 2) |
|---|---|---|
| Primary Etiology | Top-down chemical breakdown & moisture exposure (urine/stool) | Bottom-up mechanical force (pressure, shear, tissue deformation) |
| Anatomical Location | Diffuse; perineum, buttocks, inner thighs, skin folds | Localized over bony prominences (sacrum, ischium, trochanter, heels) |
| Lesion Boundaries | Diffuse, irregular, blotchy, scattered, poorly demarcated | Circumscribed, distinct, well-demarcated edges |
| Color & Erythema | Bright red, pink, non-uniform; blanches initially | Stage 1: Non-blanchable erythema; DTPI: deep red/maroon/purple |
| Depth of Damage | Partial-thickness (epidermal loss/erosion; dermis intact) | Stage 1 (intact), Stage 2 (dermal exposure), Stage 3/4 (full-thickness) |
| Necrosis / Slough | NEVER contains necrotic tissue, slough, or eschar | Slough or eschar frequently present in Stage 3, Stage 4, or Unstageable |
| Secondary Lesions | Vesicles, bullae, papules, satellite lesions (Candida) | Undermining, tunneling, epibole, exposed deep structures |
| Patient Symptoms | Burning, stinging, smarting, intense superficial pain | Deep pressure ache, localized tenderness, throbbing pain |
Prevention & Management Protocols for MASD & IAD
Effective management requires a two-pronged strategy: eliminating or mitigating the moisture source, and restoring/protecting the epidermal skin barrier.
1. Gentle Skin Cleansing Protocols
- Avoid Alkaline Bar Soap: Standard bar soaps have an alkaline pH (9.0 – 10.0) that strips natural skin lipids, neutralizes the acid mantle, and worsens enzymatic skin breakdown.
- pH-Balanced No-Rinse Cleansers: Cleanse skin immediately after each incontinent episode using a dedicated, pH-balanced (pH 5.5), non-rinse skin cleanser containing mild surfactants.
- Technique: Softly wipe or pat skin dry; avoid aggressive rubbing with rough terrycloth washcloths, which creates mechanical friction and denudes fragile skin.
2. Skin Barrier Protectant Formulations
Skin protectants form a hydrophobic barrier over the epidermis, preventing urine, feces, and moisture from contacting skin proteins.
| Protectant Active Ingredient | Mechanism of Action & Properties | Indications & Clinical Considerations |
|---|---|---|
| Petrolatum | Hydrophobic petroleum jelly base; creates an occlusive moisture barrier | Prevention of mild IAD; inexpensive; can clog incontinence pad pores if applied heavily |
| Dimethicone | Silicone-based liquid polymer; forms a breathable, water-repellent film | Ideal for daily prevention; allows transepidermal water vapor transmission; non-greasy |
| Zinc Oxide | Inorganic compound; thick, viscous physical barrier ointment | Excellent protection against aggressive liquid stool and enzymatic diarrhea; highly durable |
| Cyanoacrylates | Alcohol-free liquid skin protectant forming a durable polymeric film | Severe IAD with denuded, weeping skin; forms transparent barrier; lasts up to 72 hours |
- Clinical Removal Rule for Zinc Oxide: Zinc oxide ointment is intentionally difficult to wash off. Clinicians must not scrub zinc oxide off completely during routine incontinence care, as forceful scrubbing causes friction damage. Only the top soiled layer should be gently wiped away, leaving the clean base layer intact before applying a fresh layer.
3. Management of Fungal Superinfections
Secondary fungal infection—predominantly by Candida albicans—frequently complicates IAD and Intertrigo due to warm, moist, alkaline conditions.
- Clinical Presentation: Bright red maculopapular rash, fiery red erythema, scaling edges, and pathognomonic satellite macules or pustules spreading outward from the main body of inflammation.
- Therapeutic Protocol: Apply a topical antifungal agent (e.g., nystatin or miconazole powder or cream) twice daily. Antifungal powder is preferred in moist skin folds (ITD) to absorb excess moisture. Once the antifungal agent is applied, a breathable skin barrier protectant (e.g., dimethicone) must be layered over it to preserve barrier integrity.
A patient with frequent liquid stool presents with diffuse, bright red, irregular erythema across the buttocks and inner thighs with superficial epidermal erosion. The lesion does not overlie a bony prominence and contains no slough or eschar. What is the diagnosis?
A bedbound patient with large abdominal folds presents with mirror-image erythema along the base of the inframammary folds accompanied by maceration, a musty odor, and small peripheral satellite pustules. Which condition and secondary pathogen are present?
A patient with severe enzymatic diarrhea secondary to Clostridioides difficile infection requires a skin barrier formulation to protect denuded perianal skin. Which active barrier ingredient provides the most durable physical protection against fecal digestive lipases and proteases?